Stay updated on Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial

Sign up to get notified when there's something new on the Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now shows Revision: v3.5.2, replacing the previous Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T11:05:33.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    Updated the revision from v3.4.3 to v3.5.0. No user-facing content changes are indicated.
    Difference
    0.1%
    Check dated 2026-03-18T18:14:34.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page revision was updated from v3.4.2 to v3.4.3. No study content or data appears to be altered.
    Difference
    0.1%
    Check dated 2026-03-11T15:46:17.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The page shows a new site revision (Revision: v3.4.2) and removal of older notices (Notice about funding lapse and Revision: v3.4.1), which are administrative updates. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T02:04:37.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Added a government funding notice about potential delays and operation status, and updated the revision from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-03T23:38:15.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    The page now shows a glossary, adds the 'Last Update Submitted that Met QC Criteria' label, and displays the new revision tag 'v3.4.0', while removing the older 'Last Update Submitted that met QC Criteria' label, the 'No FEAR Act data' text, and the previous revision tag 'v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-28T00:30:28.000Z thumbnail image

Stay in the know with updates to Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial page.